Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre de la Taille

Showing results (141-150 of 389) with videos related to

Pageof 39
Sort By:
World Journal of Urology|May 20, 2006
Other therapies for BPH patients: desmopressin, anti-cholinergic, anti-inflammatory drugs, and botulinum toxinAbdel-Rahmène Azzouzi, Marc Fourmarier, Francois Desgrandchamps, et al.
Scandinavian Journal of Urology|July 26, 2013
Long-term impact of positive surgical margins on biochemical recurrence after radical prostatectomy: ten years of follow-upMathieu Rouanne, Julie Rode, Alexandre Campeggi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 3, 2013
Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective studyAlexandre Campeggi, Idir Ouzaid, Evanguelos Xylinas, et al.
BJU International|December 24, 2010
Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy schemeGuillaume Ploussard, Evanguelos Xylinas, Xavier Durand, et al.
Urology|March 26, 2013
Clinical judgment versus biomarker prostate cancer gene 3: which is best when determining the need for repeat prostate biopsy?Bertrand Tombal, Gerald L Andriole, Alexandre de la Taille, et al.
Current Urology Reports|March 22, 2003
Laparoscopic and robotic surgical training in urologyAndrás Hoznek, Ran Katz, Matthew Gettman, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 20, 2007
[Value of antidiuretic, anticholinergic, and anti-inflammatory drugs and botulinum toxin for the treatment of voiding disorders related to BPH (CTMH-AFU forum 2005)]Alexandre De la Taille, Marc Fourmarier, Francois Desgrandchamps, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|November 11, 2020
Functional outcomes after robot-assisted pyeloplasty for ureteropelvic junction obstruction: A bi-centre experienceMarie-Bérénice Popelin, Ugo Pinar, Daniel Benamran, et al.
World Journal of Urology|September 10, 2025
Algorithm to detect ISUP ≥ 2 prostate cancer using canine detectionMargaux Hermieu, Alice Roux, Loïc Desquilbet, et al.
BJU International|September 16, 2010
Transforming growth factor β-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammationAurelien Descazeaud, Nicolas Weinbreck, Grégoire Robert, et al.
Pageof 39

Showing results (141-150 of 389) with videos related to

Sort By:
Pageof 39
World Journal of Urology|May 20, 2006
Other therapies for BPH patients: desmopressin, anti-cholinergic, anti-inflammatory drugs, and botulinum toxinAbdel-Rahmène Azzouzi, Marc Fourmarier, Francois Desgrandchamps, et al.
Scandinavian Journal of Urology|July 26, 2013
Long-term impact of positive surgical margins on biochemical recurrence after radical prostatectomy: ten years of follow-upMathieu Rouanne, Julie Rode, Alexandre Campeggi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 3, 2013
Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective studyAlexandre Campeggi, Idir Ouzaid, Evanguelos Xylinas, et al.
BJU International|December 24, 2010
Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy schemeGuillaume Ploussard, Evanguelos Xylinas, Xavier Durand, et al.
Urology|March 26, 2013
Clinical judgment versus biomarker prostate cancer gene 3: which is best when determining the need for repeat prostate biopsy?Bertrand Tombal, Gerald L Andriole, Alexandre de la Taille, et al.
Current Urology Reports|March 22, 2003
Laparoscopic and robotic surgical training in urologyAndrás Hoznek, Ran Katz, Matthew Gettman, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 20, 2007
[Value of antidiuretic, anticholinergic, and anti-inflammatory drugs and botulinum toxin for the treatment of voiding disorders related to BPH (CTMH-AFU forum 2005)]Alexandre De la Taille, Marc Fourmarier, Francois Desgrandchamps, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|November 11, 2020
Functional outcomes after robot-assisted pyeloplasty for ureteropelvic junction obstruction: A bi-centre experienceMarie-Bérénice Popelin, Ugo Pinar, Daniel Benamran, et al.
World Journal of Urology|September 10, 2025
Algorithm to detect ISUP ≥ 2 prostate cancer using canine detectionMargaux Hermieu, Alice Roux, Loïc Desquilbet, et al.
BJU International|September 16, 2010
Transforming growth factor β-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammationAurelien Descazeaud, Nicolas Weinbreck, Grégoire Robert, et al.
Pageof 39